Thursday 30 June 2016

What are proteolytic enzymes as a therapeutic supplement?


Overview

Proteolytic enzymes (proteases) help the body digest the proteins in food.
Although the body produces these enzymes in the pancreas, certain foods also
contain proteolytic enzymes. Papaya and pineapple are two of the richest plant
sources, as attested by their traditional use as natural tenderizers for meat.
Papain and bromelain are the names for the
proteolytic enzymes found in these fruits. The enzymes made in the human body are
called trypsin and chymotrypsin.




The primary use of proteolytic enzymes is as a digestive aid for people who have
trouble digesting proteins. However, proteolytic enzymes may also be absorbed
internally to some extent and may reduce pain and inflammation.




Requirements and Sources

People do not need to get proteolytic enzymes from food, because the body manufactures them (primarily trypsin and chymotrypsin). However, deficiencies in proteolytic enzymes do occur, usually resulting from diseases of the pancreas (pancreatic insufficiency). Symptoms include abdominal discomfort, gas, indigestion, poor absorption of nutrients, and passing undigested food in the stool.


For use as a supplement, trypsin and chymotrypsin are extracted from the pancreas of various animals. Bromelain extracted from pineapple stems and papain made from papayas can also be purchased.




Therapeutic Dosages

The amount of an enzyme is expressed not only in grams or milligrams but also in activity units or international units. These terms refer to the enzyme’s potency (specifically, its digestive power). Recommended dosages of proteolytic enzymes vary with the form used. Because of the wide variation, label instructions regarding dosage should be followed.


Proteolytic enzymes can be broken down by stomach acid. To prevent this from happening, supplemental enzymes are often coated with a substance that does not dissolve until it reaches the intestine. Such a preparation is called enteric-coated.




Therapeutic Uses

The most obvious use of proteolytic enzymes is to assist digestion. However, a small double-blind, placebo-controlled trial found no benefit from proteolytic enzymes as a treatment for dyspepsia (indigestion).


Proteolytic enzymes can also be absorbed into the body whole and may help reduce inflammation and pain; however, the evidence is inconsistent. Several studies found that proteolytic enzymes might be helpful for neck pain, osteoarthritis, and post-herpetic neuralgia (an aftereffect of shingles). However, all of these studies suffer from significant limitations (such as the absence of a placebo group), and none provide substantially reliable information.


Studies performed decades ago suggest that proteolytic enzymes may help reduce the pain and discomfort that follow injuries (especially sports injuries). However, a more recent, better-designed, and far larger study failed to find any benefit. Proteolytic enzymes have also been evaluated as an aid to recovery from the pain and inflammation caused by surgery, but most studies are decades old, and in any case, the results were mixed.


A double-blind, placebo-controlled trial published in the 1960s found that use of
proteolytic enzymes helped reduce the discomfort of breast engorgement in
lactating women. A study tested bromelain for enhancing recovery from heavy
exercise by decreasing delayed-onset muscle soreness, but it found no benefits.
Another study, this one using a mixed proteolytic enzyme supplement, also failed
to find any benefits. Two studies failed to find proteolytic enzymes helpful for
reducing side effects of radiation therapy for cancer.


Some alternative medicine practitioners believe that proteolytic enzymes may help reduce symptoms of food allergies, presumably by digesting the food so well that there is less to be allergic to; however, there is no scientific evidence for this proposed use.


Another theory popular in certain alternative medicine circles suggests that proteolytic enzymes can aid rheumatoid arthritis, multiple sclerosis, lupus, and other autoimmune diseases. Supposedly, these diseases are made worse when whole proteins from foods leak into the blood and cause immune reactions. Digestive enzymes are said to help foil this so-called leaky gut problem. Again, however, there is no meaningful evidence to substantiate this theory. Furthermore, one fairly large (301-participant) study failed to find proteolytic enzymes helpful for multiple sclerosis.




Scientific Evidence

Most of the studies described in this section used combination products containing various proteolytic enzymes plus other substances, such as the bioflavonoid rutin.



Chronic musculoskeletal pain. Several studies provide preliminary evidence that proteolytic enzymes might be helpful for various forms of chronic pain, including neck pain and osteoarthritis. A double-blind, placebo-controlled trial of thirty people with chronic neck pain found that use of a proteolytic enzyme mixture modestly reduced pain symptoms compared with a placebo.



Osteoarthritis. Studies enrolling a total of more than four hundred people compared proteolytic enzymes to the standard anti-inflammatory drug diclofenac for the treatment of osteoarthritis-related conditions of the shoulder, back, or knee. The results generally showed that the supplement had benefits equivalent to those of the medication. However, all of these studies suffered from various flaws that limit their reliability; the most important flaw was the absence of a placebo group.



Shingles (herpes zoster).
Shingles is an acute, painful infection caused by the
varicella-zoster virus, the organism that causes chickenpox. Proteolytic enzymes
have been suggested as treatment. However, there is little evidence to support
their use. A double-blind study of 190 people with shingles compared proteolytic
enzymes to the standard antiviral drug acyclovir. Participants were treated for
fourteen days and their pain was assessed at intervals. Although both groups had
similar pain relief, the enzyme-treated group experienced fewer side effects.
However, since acyclovir offers minimal benefit at most, these results do not mean
very much. Similar results were seen in another double-blind study in which 90
people were given an injection of either acyclovir or enzymes, followed by a
course of oral medication for seven days.



Sports injuries. Several small studies have found proteolytic enzyme combinations helpful for the treatment of sports injuries. However, the best and largest trial by far failed to find benefit. A double-blind, placebo-controlled study of 44 people with sports-related ankle injuries found that treatment with proteolytic enzymes resulted in faster healing and reduced the time away from training by about 50 percent. Based on these results, a very large (721-participant), double-blind, placebo-controlled trial of people with sprained ankles was undertaken. This study failed to find benefit with rutin, bromelain, or trypsin, separately or in combination.


Three other small double-blind studies, involving a total of about eighty athletes, found that treatment with proteolytic enzymes significantly speeded healing of bruises and other mild athletic injuries, compared with placebo. In another double-blind trial, one hundred people were given an injection of their own blood under the skin to simulate bruising following an injury. Researchers found that treatment with a proteolytic enzyme combination significantly speeded up recovery. In addition, a double-blind, placebo-controlled trial of seventy-one people with finger fractures found that treatment with proteolytic enzymes significantly improved recovery. However, these studies were performed decades ago and are not quite up to modern standards.



Surgery. Numerous studies have evaluated various proteolytic enzymes as an aid to recovery from surgery, but the results have been mixed. Again, most of these studies are not up to modern standards. A double-blind, placebo-controlled trial of eighty people undergoing knee surgery found that treatment with mixed proteolytic enzymes after surgery significantly improved rate of recovery, as measured by mobility and swelling.


Another double-blind, placebo-controlled trial evaluated the effects of a similar mixed proteolytic enzyme product in eighty individuals undergoing oral surgery. The results showed reduced pain, inflammation, and swelling in the treated group compared with the placebo group. Benefits were also seen in another trial of mixed proteolytic enzymes for dental surgery, as well as in one study involving only bromelain.


A double-blind, placebo-controlled study of 204 women receiving episiotomies
during childbirth found evidence that a mixed proteolytic enzyme product can
reduce inflammation. Bromelain was also found helpful for reducing inflammation
following episiotomy in one double-blind, placebo-controlled trial of
160 women, but a very similar study found no benefit.


Other double-blind, placebo-controlled studies have found that bromelain reduces inflammation and pain following nasal surgery, cataract removal, and foot surgery. However, a study of 154 individuals undergoing facial plastic surgery found no benefit.


A small double-blind, placebo-controlled trial of twenty-four people having surgical extraction of third molars found that serrapeptase given during the procedure reduced postoperative pain and swelling (significant differences on days two, three, and seven).




Safety Issues

In studies, proteolytic enzymes are believed to have proven to be quite safe,
although they can occasionally cause digestive upset and allergic reactions. One
proteolytic enzyme, pancreatin, may interfere with folate absorption. In addition,
the proteolytic enzyme papain might increase the blood-thinning effects of
warfarin and possibly other anticoagulants. The proteolytic
enzyme bromelain might also cause problems if combined with drugs that thin the
blood. In addition, there are concerns that bromelain should not be mixed with
sedative drugs. Finally, bromelain may increase blood concentrations of certain
antibiotics.




Important Interactions

People taking the proteolytic enzyme pancreatin may need extra folate.
People taking warfarin (Coumadin), aspirin, or other drugs that thin the blood
should not take the proteolytic enzymes papain or bromelain except under a
doctor’s supervision. Those taking sedative drugs should not take bromelain,
except under a physician’s supervision.




Bibliography


Akhtar, N. M., et al. “Oral Enzyme Combination Versus Diclofenac in the Treatment of Osteoarthritis of the Knee.” Clinical Rheumatology 23 (2004): 410-415.



Al-Khateeb, T. H., and Y. Nusair. “Effect of the Proteolytic Enzyme Serrapeptase on Swelling, Pain, and Trismus after Surgical Extraction of Mandibular Third Molars.” International Journal of Oral Maxillofacial Surgery 37 (2008): 264-268.



Baumhackl, U., et al. “A Randomized, Double-Blind, Placebo-Controlled Study of Oral Hydrolytic Enzymes in Relapsing Multiple Sclerosis.” Multiple Sclerosis 11 (2005): 166-168.



Beck, T. W., et al. “Effects of a Protease Supplement on Eccentric Exercise-Induced Markers of Delayed-Onset Muscle Soreness and Muscle Damage.” Journal of Strength and Conditioning Research 21 (2007): 661-667.



Kerkhoffs, G. M., et al. “A Double-Blind, Randomised, Parallel Group Study on the Efficacy and Safety of Treating Acute Lateral Ankle Sprain with Oral Hydrolytic Enzymes.” British Journal of Sports Medicine 38 (2004): 431-435.



Klein, G., et al. “Efficacy and Tolerance of an Oral Enzyme Combination in Painful Osteoarthritis of the Hip: A Double-Blind, Randomised Study Comparing Oral Enzymes with Non-steroidal Anti-inflammatory Drugs.” Clinical and Experimental Rheumatology 24 (2006): 25-30.

No comments:

Post a Comment

How can a 0.5 molal solution be less concentrated than a 0.5 molar solution?

The answer lies in the units being used. "Molar" refers to molarity, a unit of measurement that describes how many moles of a solu...